A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
April 19, 2019
Seven Areas to Consider When Developing an Integrated Pharmacy Program
As the market continues to shift toward value-based care, health systems are being called to adapt. Quality improvement and cost savings are more crucial...
April 16, 2019
What We’re Watching: April 16, 2019
A series of Congressional hearings to get to the bottom of high drug prices occurred last week.
March 28, 2019
Premier Applied Sciences
For over 30 years, Premier has been at the forefront of the healthcare industry, diligently reinventing the way healthcare is delivered. From our world class...
March 26, 2019
Webinar: Improving Care for Hospital-Associated Sepsis
Watch this on-demand webinar to learn about the latest trends and real-world examples in preventing sepsis and improving sepsis care.
March 21, 2019
Margin of Excellence: Lowering the Incidence and Severity of Hospital-Associated Sepsis
This analysis highlights the major opportunities to treat sepsis in the hospital and reduce the frequency and severity of this life-threatening condition.
March 13, 2019
Premier Statement for the House Energy and Commerce Health Subcommittee Hearing on Reducing Barriers to Competition in the Drug Market
Premier voiced support for legislation the subcommittee is considering to eliminate anticompetitive behaviors and close loopholes.
March 12, 2019
What We’re Watching: March 12, 2019
Drug pricing hearings continue to command attention from the Congressional healthcare committees.
March 08, 2019
Premier Statement for the Record for Drug Pricing Hearings in the Senate Special Committee on Aging and House Ways and Means Committee
Premier urged Congress to enact policies to remove barriers to competition and accelerate the movement to value-based care.
March 05, 2019
Statement on Gottlieb’s Work to Create Greater Competition for Drugs and Lower Prices
Members of the Premier alliance wish to extend their gratitude to FDA Commissioner Scott Gottlieb for his superb leadership of the agency.
February 26, 2019
What We’re Watching: February 26, 2019
Unsealed court documents have revealed new details on the Amazon, Berkshire Hathaway, and JPMorgan health venture.
February 26, 2019
How Healthcare Providers Are Fighting the Opioid Epidemic on the Front Lines
A recent Premier analysis further illustrates how much the opioid epidemic is costing patients and the healthcare system.
February 21, 2019
Premier Inc. Projects 3.8 Percent Price Inflation for Pharmaceuticals
Strategic contracting capabilities outperform last year’s estimate.
February 12, 2019
What We’re Watching: February 12, 2019
HHS has taken a critical step forward in addressing HIT interoperability.
February 05, 2019
Baxter and Premier’s ProvideGx™ Subsidiary Collaborate to Address Drug Shortages
Strategic partnership brings a new source of supply to providers, innovating to alleviate the two-year shortage of metoprolol injection.
February 04, 2019
Blood-Pressure Medicine Will Be First Product for New Generic Drug Venture
The Wall Street Journal | ProvideGx, a new generic-drug venture, will begin supplying metoprolol in the middle of this month.
February 01, 2019
Premier Statement on the Patient Affordability Value and Efficiency Act
By Blair Childs, Senior Vice President of Public Affairs, Premier The Premier healthcare alliance applauds Senators Cassidy and Warner for proposing legislation to remove...
January 29, 2019
What We’re Watching: January 30, 2019
BUT WAIT, THERE’S MORE Tomorrow morning, the Senate Finance Committee will hold a hearing titled, “Drug Pricing in America: A Prescription for Change, Part...
January 29, 2019
Premier Urges Congressional Committees to Adopt Sustainable Solutions to Address Rising Drug Prices
Premier submitted statements for the record for today’s drug pricing hearings in the Senate Finance Committee and House Committee on Oversight and Reform. As...
January 23, 2019
Premier Provides Input on FDA Proposed Framework for Regulating Drug-Use-Related Software
Premier submitted comments to the FDA in response to its proposed framework for regulating prescription drug-use-related software applications. Premier cautioned the FDA to ensure...
January 15, 2019
Statement on AHA/FAH/ASHP Study on Drug Shortages
By Blair Childs, Senior Vice President of Public Affairs, Premier As the national leader in combating drug price increases and drug shortages, we applaud...
January 15, 2019
What We’re Watching: January 15, 2019
NO MORE SHORTAGES Even with the shutdown, FDA Commissioner Gottlieb has made it clear that funds are available to ensure no slowdown in the...
